Pepa Polavieja

927 total citations
25 papers, 733 citations indexed

About

Pepa Polavieja is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Pepa Polavieja has authored 25 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 5 papers in Clinical Psychology. Recurrent topics in Pepa Polavieja's work include Treatment of Major Depression (6 papers), Bipolar Disorder and Treatment (5 papers) and Schizophrenia research and treatment (5 papers). Pepa Polavieja is often cited by papers focused on Treatment of Major Depression (6 papers), Bipolar Disorder and Treatment (5 papers) and Schizophrenia research and treatment (5 papers). Pepa Polavieja collaborates with scholars based in Spain, United States and Canada. Pepa Polavieja's co-authors include Inmaculada Gilaberte, Irene Romera, Antonio Ciudad, Amaia Hervás, Rodrigo Escobar, Víctor Pérez, César A. Soutullo, Xavier Gastaminza, Luis San and Enric Álvarez and has published in prestigious journals such as PEDIATRICS, Journal of Affective Disorders and Psychiatry Research.

In The Last Decade

Pepa Polavieja

25 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pepa Polavieja Spain	15	469	235	172	161	104	25	733
M. Konings Netherlands	5	418 0.9×	239 1.0×	131 0.8×	155 1.0×	114 1.1×	8	634
S. O. W. Jensen Denmark	14	363 0.8×	176 0.7×	137 0.8×	137 0.9×	151 1.5×	15	850
Francisco Pedrosa Gil Germany	17	490 1.0×	509 2.2×	86 0.5×	145 0.9×	77 0.7×	36	910
Elie Cheniaux Brazil	16	559 1.2×	301 1.3×	75 0.4×	162 1.0×	157 1.5×	78	957
Christoph U. Correll United States	16	458 1.0×	193 0.8×	78 0.5×	82 0.5×	83 0.8×	46	669
Ioannis Nimatoudis Greece	14	243 0.5×	166 0.7×	105 0.6×	152 0.9×	206 2.0×	52	726
Moritz Muehlbacher Austria	17	407 0.9×	474 2.0×	159 0.9×	117 0.7×	81 0.8×	27	948
Azorin Jm France	15	425 0.9×	142 0.6×	143 0.8×	74 0.5×	58 0.6×	64	608
Davide Prestía Italy	13	448 1.0×	406 1.7×	76 0.4×	213 1.3×	96 0.9×	25	914
Anna Ceraso Italy	11	528 1.1×	171 0.7×	63 0.4×	149 0.9×	212 2.0×	18	714

Countries citing papers authored by Pepa Polavieja

Since Specialization

Citations

This map shows the geographic impact of Pepa Polavieja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pepa Polavieja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pepa Polavieja more than expected).

Fields of papers citing papers by Pepa Polavieja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pepa Polavieja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pepa Polavieja. The network helps show where Pepa Polavieja may publish in the future.

Co-authorship network of co-authors of Pepa Polavieja

This figure shows the co-authorship network connecting the top 25 collaborators of Pepa Polavieja. A scholar is included among the top collaborators of Pepa Polavieja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pepa Polavieja. Pepa Polavieja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lanctôt, Krista L., Linus Jönsson, Alireza Atri, et al.. (2025). Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(2). e70081–e70081. 1 indexed citations

Irimia, Pablo, David García‐Azorín, Mercedes Núñez, et al.. (2022). Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study. The Journal of Headache and Pain. 23(1). 78–78. 22 indexed citations

Irimia, Pablo, David García‐Azorín, Mercedes Núñez, et al.. (2021). Persistence, use of resources and costs in patients who start preventive medication for the treatment of migraine in Spain: The persec study. Journal of the Neurological Sciences. 429. 119343–119343. 1 indexed citations

Romera, Irene, Víctor Pérez, Antonio Ciudad, et al.. (2013). Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis. BMC Psychiatry. 13(1). 51–51. 62 indexed citations

Romera, Irene, Ángel L. Montejo, Fernando Caballero, et al.. (2011). Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: post hoc analysis of a cross-sectional study. BMC Psychiatry. 11(1). 69–69. 13 indexed citations

Ciudad, Antonio, Enric Álvarez, Miquel Roca, et al.. (2011). Early Response and Remission as Predictors of a Good Outcome of a Major Depressive Episode at 12-Month Follow-Up. The Journal of Clinical Psychiatry. 73(2). 185–191. 29 indexed citations

Ciudad, Antonio, Luis San, Miquel Bernardo, et al.. (2011). Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 36(2). 245–250. 17 indexed citations

Calle, Alfonso, et al.. (2011). Blood glucose control and quality of health care in non‐insulin‐treated patients with Type 2 diabetes in Spain: a retrospective and cross‐sectional observational study. Diabetic Medicine. 28(6). 731–740. 14 indexed citations

Ciudad, Antonio, Luis San, Miquel Bernardo, et al.. (2011). Non-adherence to oral antipsychotics in schizophrenia: Relapse and therapeutic strategies in a 12-month observational study. European Psychiatry. 26(S2). 1362–1362. 1 indexed citations

10.

Montoya, Alonso, Mauricio Tohen, Eduard Vieta, et al.. (2010). Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: A 1-year, prospective, observational cohort study. Journal of Affective Disorders. 127(1-3). 50–57. 20 indexed citations

11.

Polavieja, Pepa, et al.. (2010). Prevalencia del síndrome metabólico y grado de concordancia en su diagnóstico en pacientes con diabetes mellitus tipo 2 en España. Endocrinología y Nutrición. 57(2). 60–70. 7 indexed citations

12.

Romera, Irene, Víctor Pérez, José M. Menchón, Pepa Polavieja, & Inmaculada Gilaberte. (2010). Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning. Psychiatry Research. 186(1). 133–137. 45 indexed citations

13.

Romera, Irene, Ángel L. Montejo, Fernando Caballero, et al.. (2010). Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: Prevalence of painful somatic symptoms, functioning and health status. Journal of Affective Disorders. 127(1-3). 160–168. 50 indexed citations

14.

Escobar, Rodrigo, Alonso Montoya, Pepa Polavieja, et al.. (2009). Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 19(3). 253–263. 39 indexed citations

15.

Romera, Irene, et al.. (2009). Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study. European Psychiatry. 25(1). 58–65. 76 indexed citations

16.

Ciudad, Antonio, Enric Álvarez, Julio Bobes, et al.. (2009). Remission in schizophrenia: Results from a 1-year follow-up observational study. Schizophrenia Research. 108(1-3). 214–222. 49 indexed citations

17.

Bobes, Julio, Antonio Ciudad, Enric Álvarez, et al.. (2009). Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remission. Schizophrenia Research. 115(1). 58–66. 67 indexed citations

18.

Zoreda, Luís Caballero, Enric Aragonès, Javier Garcı́a-Campayo, et al.. (2008). Prevalence, Characteristics, and Attribution of Somatic Symptoms in Spanish Patients With Major Depressive Disorder Seeking Primary Health Care. Psychosomatics. 49(6). 520–529. 31 indexed citations

19.

Montoya, Alonso, Luis San, J.M. Olivares, et al.. (2008). Clinical characteristics of agitated psychotic patients treated with an oral antipsychotics attended in the emergency room setting: NATURA study. International Journal of Psychiatry in Clinical Practice. 12(2). 127–133. 2 indexed citations

20.

Escobar, Rodrigo, César A. Soutullo, Amaia Hervás, et al.. (2005). Worse Quality of Life for Children With Newly Diagnosed Attention-Deficit/Hyperactivity Disorder, Compared With Asthmatic and Healthy Children. PEDIATRICS. 116(3). e364–e369. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact